Buy Shaily Engineering; target of Rs 4074: Motilal Oswal

Moneycontrol • 1 day ago

Original source

Key Investment Pillars

  • Healthcare segment growth: Shaily Engineering's healthcare segment is expected to drive growth, with a 78% YoY increase in revenue, driven by increasing traction in GLP-1 pen sales.
  • Pen capacity expansion: The company is expanding its pen capacity, with a new 25m capacity expected to start selling from Dec'26, which will help meet growing demand.
  • Diversification into new products: Shaily Engineering is diversifying into new products, such as a two-step reusable auto-injector pen, Shaily AI Toby, for GLP-1 therapy, which will help reduce dependence on a single product.
  • Improving margins: The company's EBITDA margin is expected to expand, driven by a greater revenue mix of higher-margin healthcare segment and improving operational efficiency.

Thesis Validation Checklist

To validate the investment thesis, watch for:

  • GLP-1 pen sales growth: Continued strong growth in GLP-1 pen sales, with a target of 36m devices in FY27.
  • Pen capacity utilization: Improvement in pen capacity utilization, which will help drive revenue growth and margin expansion.
  • New product launches: Successful launch of new products, such as the eye applicator and Shaily AI Toby, which will help diversify revenue streams.
  • Margin expansion: Continued expansion of EBITDA margin, driven by operational efficiency and a greater revenue mix of higher-margin products.